0IZX Stock Overview

0IZX fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	2/6
Financial Health	6/6
Dividends	0/6

Risk Analysis

Shareholders have been substantially diluted in the past year

Shares are highly illiquid

Profit margins (5.4%) are lower than last year (11.2%)

My Notes

Capture your thoughts, links and company narrative

Elos Medtech AB (publ) Competitors

NIOX Group

AIM:NIOX

UK£251.5m

EKF Diagnostics Holdings

AIM:EKF

UK£122.1m

Smith & Nephew

LSE:SN.

UK£8.5b

Advanced Medical Solutions Group

AIM:AMS

UK£428.3m

Price History & Performance

Summary of share price highs, lows and changes for Elos Medtech
Historical stock prices
Current Share Price	SEK 199.99
52 Week High	SEK 199.99
52 Week Low	SEK 199.99
Beta	1.12
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	247.80%

Recent updates

Shareholder Returns

	0IZX	GB Medical Equipment	GB Market
7D	n/a	-2.3%	-2.2%
1Y	n/a	-10.6%	2.4%

Return vs Industry: Insufficient data to determine how 0IZX performed against the UK Medical Equipment industry.

Return vs Market: Insufficient data to determine how 0IZX performed against the UK Market.

Price Volatility

Is 0IZX's price volatile compared to industry and market?
0IZX volatility
0IZX Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	6.5%
Market Average Movement	4.8%
10% most volatile stocks in GB Market	10.5%
10% least volatile stocks in GB Market	2.6%

Stable Share Price: 0IZX has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine 0IZX's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1923	653	Stefano Alfonsi	elosmedtech.com

Elos Medtech AB (publ) engages in the development and contract manufacturing of medical devices and components for dental, orthopedics, diagnostics, and hearing and other medical device markets. It offers implants, screws, plates, orthopedic and dental instruments, drills, pins and wires, dental prosthetics, disposable plastic products, HPLC fittings, and other medical plastic parts. The company also provides design and development, regulatory, prototyping, testing, OEM, process validation, and supply and inventory management, as well as design for manufacturing and engineering services.

Elos Medtech AB (publ) Fundamentals Summary

How do Elos Medtech's earnings and revenue compare to its market cap?
0IZX fundamental statistics
Market cap	SEK 5.73b
Earnings (TTM)	SEK 54.95m
Revenue (TTM)	SEK 1.02b

104.3x

P/E Ratio

5.6x

P/S Ratio

Is 0IZX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0IZX income statement (TTM)
Revenue	SEK 1.02b
Cost of Revenue	SEK 676.62m
Gross Profit	SEK 341.02m
Other Expenses	SEK 286.07m
Earnings	SEK 54.95m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Feb 29, 2024

Earnings per share (EPS)	1.95
Gross Margin	33.51%
Net Profit Margin	5.40%
Debt/Equity Ratio	51.6%

How did 0IZX perform over the long term?

See historical performance and comparison

Dividends

0.5%

Current Dividend Yield

15%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2023/12/21 01:16
End of Day Share Price	2023/12/18 00:00
Earnings	2023/09/30
Annual Earnings	2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Elos Medtech AB (publ) is covered by 2 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Oskar Vikström	ABG Sundal Collier Sponsored
Andreas Kvist	Redeye

Elos Medtech LSE:0IZX Stock Report